Compare RGS & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGS | RPID |
|---|---|---|
| Founded | 1922 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7M | 84.8M |
| IPO Year | 1994 | 2021 |
| Metric | RGS | RPID |
|---|---|---|
| Price | $27.00 | $1.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 4.1K | ★ 227.1K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.24 | 2.78 |
| EPS | ★ 0.89 | N/A |
| Revenue | ★ $210,134,000.00 | $33,587,000.00 |
| Revenue This Year | N/A | $19.12 |
| Revenue Next Year | N/A | $18.42 |
| P/E Ratio | $30.34 | ★ N/A |
| Revenue Growth | 3.52 | ★ 19.74 |
| 52 Week Low | $19.31 | $1.52 |
| 52 Week High | $31.50 | $4.94 |
| Indicator | RGS | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 46.12 | 36.60 |
| Support Level | $25.96 | $1.52 |
| Resistance Level | $28.44 | $2.18 |
| Average True Range (ATR) | 0.96 | 0.12 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 16.22 | 37.04 |
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.